Home
 /
Papers
 /
Immunology
 /
Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fate
Preprint
Open access
V1
Top 1% · Validated by QED

Signaling induced biophysical disruption of repressed chromatin domains drives immune cell fate

Alexia Martínez de Paz, Christopher R. Chin, Mythili Ketavarapu +32 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.08.692984
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Immunology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By demonstrating that signal-induced H3S28 phosphorylation directly dismantles PRC2 compaction and overrides H3K27me3 repression, this work solves a fundamental mystery: how extracellular signals rapidly unlock repressed chromatin domains to execute cell fate decisions.

QED claims analysis

Summary

Signal-induced histone H3 serine phosphorylation at repressed chromatin domains drives immune cell fate transitions by antagonizing Polycomb Repressive Complex 2 through multiple mechanisms—disrupting nucleosome binding, blocking allosteric activation, preventing chromatin compaction—thereby enabling rapid derepression of lineage-defining genes and translating signaling quality into cell fate probabilities across diverse immune cell types.

See full analysis
Main Claim 1 –

Transitional chromatin co-localizes H3K27me3 with H3S28ph at fate genes

Supporting evidence

  • H3S28ph derepresses Polycomb domains across immune cell lineages
Main Claim 2 –

Immune synapse signaling strength drives H3 phosphorylation at GC selection genes

Main Claim 3 –

H3.3 S28/S31 phosphorylation controls germinal center B cell fate transitions

Main Claim 4 –

H3 phosphorylation inhibits PRC2 binding, activity, and chromatin compaction

Supporting evidence

  • H3ph drives H3K27me3 loss, H3K27ac gain, and TAD interactivity
  • H3 phosphorylation promotes H3K36me2 to stabilize chromatin activation

Abstract

Cell fate transitions require signal-induced chromatin derepression, yet mechanisms governing transitions from repressed to active chromatin states are poorly understood. We discover, at fate-defining genes across immune cell types, a signal-induced histone code, and describe domains of H3 serine 28 phosphorylation (H3S28ph) spanning architectural features, often coincident with repressive H3 lysine 27 trimethylation (H3K27me3). Employing biophysical, single cell, and functional approaches to study signal-induced cell differentiation in the immune system, we uncover epigenomic transitions and cell fate choices precipitated by histone phosphorylation (H3ph). Mechanistically, H3ph overrides Polycomb Repressive Complex 2 (PRC2) chromatin repression, biophysically disrupts polynucleosome compaction, and promotes loss of H3K27me3, while increasing activating H3K27 acetylation and H3K36 dimethylation to drive domain interactivity and stabilize transcription. We demonstrate the activity of H3ph in several cell fate transitions and illuminate biophysical mechanisms enabling rapid signal-activated chromatin derepression, processes with general relevance for cellular differentiation and activation.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?